Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Hartmann

Showing results (351-360 of 472) with videos related to

Pageof 48
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 18, 2015
Time to Definitive Failure to the First Tyrosine Kinase Inhibitor in Localized GI Stromal Tumors Treated With Imatinib As an Adjuvant: A European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Intergroup Randomized Trial in Collaboration With the Australasian Gastro-Intestinal Trials Group, UNICANCER, French Sarcoma Group, Italian Sarcoma Group, and Spanish Group for Research on SarcomasPaolo G Casali, Axel Le Cesne, Andres Poveda Velasco, et al.
Journal of Neurochemistry|July 1, 1999
Alzheimer's disease: correlation of the suppression of beta-amyloid peptide secretion from cultured cells with inhibition of the chymotrypsin-like activity of the proteasomeG Christie, R E Markwell, C W Gray, et al.
The Journal of Prevention of Alzheimer'S Disease|January 31, 2022
Multimodal Preventive Trial for Alzheimer's Disease: MIND-ADmini Pilot Trial Study Design and ProgressS Sindi, C Thunborg, A Rosenberg, et al.
Seminars in Oncology|May 13, 1998
The use of dose-intensified chemotherapy in the treatment of metastatic nonseminomatous testicular germ cell tumors. German Testicular Cancer Study GroupC Bokemeyer, A Harstrick, J Beyer, et al.
JAMA Oncology|April 28, 2017
Effect of Neoadjuvant Chemotherapy Followed by Surgical Resection on Survival in Patients With Limited Metastatic Gastric or Gastroesophageal Junction Cancer: The AIO-FLOT3 TrialSalah-Eddin Al-Batran, Nils Homann, Claudia Pauligk, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 16, 2001
Viable malignant cells after primary chemotherapy for disseminated nonseminomatous germ cell tumors: prognostic factors and role of postsurgery chemotherapy--results from an international study groupK Fizazi, S Tjulandin, R Salvioni, et al.
Lancet (London, England)|April 16, 2019
Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trialSalah-Eddin Al-Batran, Nils Homann, Claudia Pauligk, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 16, 2012
Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancerJ Beyer, P Albers, R Altena, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 21, 2004
European consensus on diagnosis and treatment of germ cell cancer: a report of the European Germ Cell Cancer Consensus Group (EGCCCG)H J Schmoll, R Souchon, S Krege, et al.
European Urology|January 15, 2008
European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus Group (EGCCCG): part IISusanne Krege, Jörg Beyer, Rainer Souchon, et al.
Pageof 48

Showing results (351-360 of 472) with videos related to

Sort By:
Pageof 48
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 18, 2015
Time to Definitive Failure to the First Tyrosine Kinase Inhibitor in Localized GI Stromal Tumors Treated With Imatinib As an Adjuvant: A European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Intergroup Randomized Trial in Collaboration With the Australasian Gastro-Intestinal Trials Group, UNICANCER, French Sarcoma Group, Italian Sarcoma Group, and Spanish Group for Research on SarcomasPaolo G Casali, Axel Le Cesne, Andres Poveda Velasco, et al.
Journal of Neurochemistry|July 1, 1999
Alzheimer's disease: correlation of the suppression of beta-amyloid peptide secretion from cultured cells with inhibition of the chymotrypsin-like activity of the proteasomeG Christie, R E Markwell, C W Gray, et al.
The Journal of Prevention of Alzheimer'S Disease|January 31, 2022
Multimodal Preventive Trial for Alzheimer's Disease: MIND-ADmini Pilot Trial Study Design and ProgressS Sindi, C Thunborg, A Rosenberg, et al.
Seminars in Oncology|May 13, 1998
The use of dose-intensified chemotherapy in the treatment of metastatic nonseminomatous testicular germ cell tumors. German Testicular Cancer Study GroupC Bokemeyer, A Harstrick, J Beyer, et al.
JAMA Oncology|April 28, 2017
Effect of Neoadjuvant Chemotherapy Followed by Surgical Resection on Survival in Patients With Limited Metastatic Gastric or Gastroesophageal Junction Cancer: The AIO-FLOT3 TrialSalah-Eddin Al-Batran, Nils Homann, Claudia Pauligk, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 16, 2001
Viable malignant cells after primary chemotherapy for disseminated nonseminomatous germ cell tumors: prognostic factors and role of postsurgery chemotherapy--results from an international study groupK Fizazi, S Tjulandin, R Salvioni, et al.
Lancet (London, England)|April 16, 2019
Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trialSalah-Eddin Al-Batran, Nils Homann, Claudia Pauligk, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 16, 2012
Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancerJ Beyer, P Albers, R Altena, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 21, 2004
European consensus on diagnosis and treatment of germ cell cancer: a report of the European Germ Cell Cancer Consensus Group (EGCCCG)H J Schmoll, R Souchon, S Krege, et al.
European Urology|January 15, 2008
European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus Group (EGCCCG): part IISusanne Krege, Jörg Beyer, Rainer Souchon, et al.
Pageof 48